Valuation: Perrigo Company

Market Cap 144.87Cr 126.94Cr 117.84Cr 108.29Cr 204.05Cr 14TCr 207.05Cr 1.4TCr 549.45Cr 6.84TCr 543.83Cr 532.11Cr 24TCr P/E 2026 *
-74.8x
P/E 2027 * 9.03x
Enterprise Value 438.77Cr 384.45Cr 356.91Cr 327.96Cr 618Cr 42TCr 627.09Cr 4.25TCr 1.66TCr 21TCr 1.65TCr 1.61TCr 72TCr EV / Sales 2026 *
1.08x
EV / Sales 2027 * 1.04x
Free-Float
99.6%
Yield 2026 *
11%
Yield 2027 * 11.3%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%+0.55%+49.79%+151.71% 1,03700Cr
+2.00%+3.49%+52.22%+50.20% 62TCr
-1.09%+3.76%+35.37%+76.22% 45TCr
-0.42%+0.67%+30.81%+21.05% 33TCr
-0.16%+2.74%+36.02%+37.33% 29TCr
+1.68%+1.08%+22.70%+17.94% 26TCr
-1.40%-3.34%-24.63%-42.39% 22TCr
-0.05%+2.16%+19.75%+55.89% 20TCr
+0.05%-1.03%+18.31%+61.63% 16TCr
Average -0.28%+1.12%+26.70%+47.73% 39.53TCr
Weighted average by Cap. -0.46%+1.47%+35.90%+72.17%

Financials

2026 *2027 *
Net sales 405.62Cr 355.41Cr 329.94Cr 303.19Cr 571.31Cr 39TCr 579.72Cr 3.93TCr 1.54TCr 19TCr 1.52TCr 1.49TCr 66TCr 409.85Cr 359.11Cr 333.38Cr 306.34Cr 577.26Cr 40TCr 585.75Cr 3.97TCr 1.55TCr 19TCr 1.54TCr 1.51TCr 67TCr
Net income -34Cr -30Cr -28Cr -25Cr -48Cr -3.27TCr -48Cr -328.5Cr -128.57Cr -1.6TCr -127.26Cr -124.51Cr -5.53TCr 16Cr 14Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 156.4Cr 61Cr 762.07Cr 61Cr 59Cr 2.63TCr
Net Debt 293.9Cr 257.52Cr 239.06Cr 219.68Cr 413.95Cr 28TCr 420.04Cr 2.85TCr 1.11TCr 14TCr 1.1TCr 1.08TCr 48TCr 282.8Cr 247.79Cr 230.04Cr 211.38Cr 398.32Cr 27TCr 404.18Cr 2.74TCr 1.07TCr 13TCr 1.06TCr 1.04TCr 46TCr
Logo Perrigo Company
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-